Clinical Trials Logo

Clinical Trial Summary

This study is to evaluate and directly compare the technical success, tissue quality, diagnostic efficacy and safety profile of Percutaneous and Endoscopic Ultrasound-guided Liver Biopsy.


Clinical Trial Description

Liver biopsy (LB) is essential for the diagnosis and evaluation of a variety of hepatic conditions, such as grading/staging of chronic liver disease secondary to alcohol, non-alcoholic steatohepatitis, viral hepatitis, hemochromatosis, Wilson's disease, cholestatic liver disease, as well as in elucidating the etiology of elevation in liver tests.1 Since it was first performed in 1883, percutaneous (PC) liver biopsy has become routine practice and is usually performed under the guidance of real-time imaging using transabdominal ultrasound (US) or computed tomography (CT).1,2 However, in recent times, liver biopsy has been increasingly performed via transgastric or transduodenal routes under endoscopic ultrasound (EUS) guidance. The perceived advantages of performing EUS-LB compared to PC-LB are the ability to simultaneously assess other organs such as common bile duct and pancreas, access to both left and right lobes of the liver and the routine use of conscious sedation during EUS procedures.3 Although single arm cohort studies and retrospective comparative studies assessing the technical success, tissue quality and safety of these different liver biopsy modalities exist, currently there are no randomized trials comparing PC and EUS-guided LB.4-7 ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04003766
Study type Interventional
Source AdventHealth
Contact
Status Completed
Phase N/A
Start date July 25, 2019
Completion date February 11, 2022

See also
  Status Clinical Trial Phase
Completed NCT00643656 - Use of 50% Nitrous Oxide / 50% Oxygen Premix During Liver Biopsy of Focal Lesion Phase 4
Enrolling by invitation NCT04170452 - Study the Content of the HBV DNA in Liver Biopsy in the Patients Chronic Hepatitis Delta
Recruiting NCT03142698 - Evaluation of 4 MRI Methods (PDFF 3, 6 and 11 Gradient Echoes and Spectroscopy) Compared to the Reference Method (Liver Biopsy) in Quantification of Hepatic Steatosis N/A
Withdrawn NCT03910790 - Liver Biopsy Using a 19 Gauge Fine Needle Biopsy Needle N/A
Recruiting NCT03173287 - Quantification of Hepatic Fibrosis by IVIM Sequences in 1.5T MRI N/A
Completed NCT02620228 - Identification of Liver Tumours Using BIP - Biopsy System N/A
Terminated NCT02573545 - Evaluation of a Support Software in the Planning and Real-time Monitoring of the Insertion of Needles in Interventional Magnetic Resonance Imaging (MRI): Liver Biopsy Case N/A
Withdrawn NCT04039529 - Novel Guidance Device for Image Fusion and Needle Guidance in Lung, Liver or Kidney Biopsy N/A
Terminated NCT03040323 - Prospective Analysis of Value of Contrast-enhanced Sonography During Biopsies of Focal Liver Masses Phase 4
Recruiting NCT05614973 - Efficacy and Safety of Percutaneous Liver Biopsy With Needle Tract Plugging on Outpatient Basis N/A